76
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats

, , , , , & show all
Pages 1103-1111 | Published online: 08 Dec 2010

References

  • JeongYISeoSJParkIKCellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(γ-benzyl-L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moietyInt J Pharm200529615116115885467
  • Martinez-BarbosaMEBouteillerLCammas-MarionSMontembaultVFontaineLPonchelGSynthesis and ITC characterization of novel nanoparticles constituted by poly(γ-benzyl L-glutamate)-β-cyclodextrinJ Mol Recognit20082116917818438968
  • ZhuZLiYLiXPaclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(ɛ-caprolactone) nanoparticles: preparation and antitumor activity in vivoJ Control Release201014243844619896997
  • WangLYWangSGBeiJZSynthesis and characterization of macroinitiator-amino terminated PEG and poly(γ-benzyl-Lglutamate)-PEO-poly(γ-benzyl-L-glutamate) triblock copolymerPolym Adv Technol200415617621
  • CheonJBJeongYIChoCSEffects of temperature on diblock copolymer micelle composed of poly(γ-benzyl L-glutamate) and poly(Nisopropylacrylamide)Polymer20064020412050
  • QiLXuZIn vivo antitumor activity of chitosan nanoparticlesBioorg Med Chem Lett2006164243424516759859
  • GezeAChauLTChoisnardLBiodistribution of intravenously administered amphiphilic β-cyclodextrin nanospheresInt J Pharm200734413514217692481
  • GaumetMVargasAGurnyRDelieFNanoparticles for drug delivery: The need for precision in reporting particle size parametersEur J Pharm Biopharm2008691917826969
  • NanjwadeBKSinghJParikhKAManviFVPreparation and evaluation of carboplatin biodegradable polymeric nanoparticlesInt J Pharm201038517618019854254
  • ChengJTeplyBASherifiIFormulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomater200728869876
  • GovenderTRileyTEhtezaziTDefining the drug incorporation properties of PLA–PEG nanoparticlesInt J Pharm20001999511010794931
  • BudhianASiegelSJWineyKIHaloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug contentInt J Pharm200733636737517207944
  • SepassiSGoodwinDJDrakeAFEffect of polymer molecular weight on the production of drug nanoparticlesJ Pharm Sci2007962655266617696165
  • MoghimiSMSzebeniJStealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesProg Lipid Res20034246347814559067
  • OwensDEPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm20063079310216303268
  • DecuzziPGodinBTanakaTSize and shape effects in the biodistribution of intravascularly injected particlesJ Control Release201014132032719874859
  • AvgoustakisKBeletsiAPanagiZEffect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA–mPEG nanoparticlesInt J Pharm200325911512712787641
  • YangTCuiFDChoiMKEnhanced solubility and stability of pegylated liposomal paclitaxel: in vitro and in vivo evaluationInt J Pharm200733831732617368984
  • ParkJFongPMLuJPegylated PLGA nanoparticles for the improved delivery of doxorubicinNanomedicine2009541041819341815
  • BhadraDBhadraSJainPJainNKPegnology: a review of PEGylated systemsPharmazie20025752911836932
  • VeroneseFMPasutGPegylation, successful approach for drug deliveryDrug Discov Today2005101451145816243265
  • Diaz-LopezRTsapisNSantinMThe performance of pegylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agentBiomater20103117231731
  • GrefRDombAQuellecPThe controlled intravenous delivery of drugs using PEG coated sterically stabilized nanospheresAdv Drug Deliv Rev199516215233
  • ZhenXLKanBGouMLPreparation of mPEG–PLA nanoparticle for honokiol delivery in vitroInt J Pharm201038626226719932160
  • RedheadHMDavisSSIllumLDrug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluationJ Control Release20017035336311182205
  • ZambauxMFFaivre-FiorinaBBonneauxFInvolvement of neutrophilic granulocytes in the uptake of biodegradable non-stealth and stealth nanoparticles in guinea pigBiomaterials20002197598010768748
  • Martinez-BarbosaMEMontembaultVCammas-MarionSPonchelGFontaineLSynthesis and characterization of novel poly(γ-benzyl-Lglutamate) derivatives tailored for the preparation of nanoparticles of pharmaceutical interestPolym Int200756317324
  • Martinez-BarbosaMECammas-MarionSBouteillerLVauthierCPonchelGPegylated degradable composite nanoparticles based on mixtures of PEG-b-poly(γ-benzyl L-glutamate) and poly(γ-benzyl L-glutamate)Bioconjugate Chem20092014901496
  • Segura-SánchezFMontembaultVFontaineLMartínez-BarbosaEBouchemalKPonchelGSynthesis and characterization of functionalized poly(γ-benzyl-L-glutamate) derivates and corresponding nanoparticles preparation and characterizationInt J Pharm201038724425220005933
  • OzcanISegura-SánchezFBouchemalKEffects of sterilization techniques on the PEGylated poly(γ-benzyl-L-glutamate) (PBLG) nanoparticlesActa Pharm Sciencia200951211218
  • DawsonBTrappRGBasic and Clinical BiostatisticsUSAMcGraw Hill2001161182
  • MuLFengSSA novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGSJ Control Release200386334812490371
  • SongXZhaoYWuWPLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiencyInt J Pharm200835032032917913411
  • HuangMJGouMLQianZYOne-step preparation of poly(epsiloncaprolactone)– poly(ethylene glycol)–poly(epsiloncaprolactone) nanoparticles for plasmid DNA deliveryJ Biomed Mater Res A20088697998618067161
  • WangDMillerSSimaMKopeckovaPKopecekJSynthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systemsBioconjugate Chem200314853859
  • PeracchiaMTFattalEDesmaeleDStealth pegylated polycyanoacrylate nanoparticles for intravenous administration and splenic targetingJ Control Release19996012112810370176
  • VilaAGillHMcCallionOAlonsoMJTransport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating densityJ Control Release20049823124415262415
  • KimTHParkTGCritical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheresInt J Pharm200427120721415129987
  • PygallSRWhetstoneJTimminsPMeliaCDPharmaceutical applications of confocal laser scanning microscopy: The physical characterisation of pharmaceutical systemsAdv Drug Del Rev20075914341452
  • ZhaoJWuJPreparation and characterization of the fluorescent chitosan nanoparticle probeChinese J Anal Chem20063415551559
  • GuoGLiuWLiangJXuHHeZYangXPreparation and characterization of novel CdSe quantum dots modified with poly (D, L-lactide) nanoparticlesMater Lett20066025652568
  • SuhJChoyKLLaiSKPEGylation of nanoparticles improves their cytoplasmic transportInt J Nanomed20072735741
  • StolnikSHealdCRNealJPolylactide–poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performanceJ Drug Target2001936137811770706
  • BeletsiAPanagiZAvgoustakisKBiodistribution properties of nanoparticles based on mixtures of PLGA with PLGA–PEG diblock copolymersInt J Pharm200529823324115936907
  • SonavaneGTomodaKMakinoKBiodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle sizeColloids Surf B Biointerfaces20086627428018722754